Quantcast

Granite State Times

Saturday, May 18, 2024

FDA conducted lowest number of inspections on Biologics companies in New Hampshire during Q4 2023

Webp 1nnkuwui7bygddwf9isz0oba9c4q

James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website

James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website

In the fourth quarter of 2023, one Biologics company received an FDA inspection in New Hampshire, according to the U.S. Food and Drug Administration (FDA).

This was the lowest number of inspections per type of company made by the FDA in New Hampshire, equalling 8.3% of all inspections in the fourth quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in New Hampshire During Q4 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products1----
Compliance: Devices11--
Drug Quality Assurance--1--
Foodborne Biological Hazards61--
Monitoring of Marketed Animal Drugs, Feed, and Devices--1--

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

MORE NEWS